Adam Almeida
Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Axons | 1 | 2023 | 203 | 0.720 |
Why?
| | Zebrafish | 1 | 2023 | 496 | 0.590 |
Why?
| | Saccharomyces cerevisiae Proteins | 3 | 2018 | 404 | 0.290 |
Why?
| | Melanoma | 3 | 2017 | 758 | 0.220 |
Why?
| | Myelin Sheath | 2 | 2023 | 171 | 0.220 |
Why?
| | Oligodendroglia | 2 | 2023 | 181 | 0.220 |
Why?
| | Central Nervous System | 2 | 2023 | 261 | 0.220 |
Why?
| | Neoplastic Stem Cells | 2 | 2017 | 398 | 0.200 |
Why?
| | Oligodendrocyte Precursor Cells | 1 | 2022 | 21 | 0.200 |
Why?
| | Saccharomyces cerevisiae | 2 | 2018 | 562 | 0.170 |
Why?
| | Nitrophenols | 2 | 2017 | 34 | 0.170 |
Why?
| | Biphenyl Compounds | 2 | 2017 | 63 | 0.160 |
Why?
| | Genomic Instability | 1 | 2018 | 54 | 0.140 |
Why?
| | Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2017 | 40 | 0.140 |
Why?
| | Sulfonamides | 2 | 2017 | 513 | 0.130 |
Why?
| | Nucleosomes | 1 | 2018 | 156 | 0.120 |
Why?
| | Oligopeptides | 1 | 2016 | 273 | 0.120 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 1060 | 0.110 |
Why?
| | Down-Regulation | 1 | 2012 | 658 | 0.080 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2012 | 429 | 0.080 |
Why?
| | Aging | 1 | 2018 | 1866 | 0.070 |
Why?
| | Apoptosis | 2 | 2016 | 2557 | 0.070 |
Why?
| | Animals | 4 | 2023 | 37011 | 0.070 |
Why?
| | Cell Self Renewal | 2 | 2017 | 54 | 0.070 |
Why?
| | Drug Synergism | 2 | 2017 | 379 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 2 | 2017 | 234 | 0.060 |
Why?
| | MicroRNAs | 1 | 2012 | 704 | 0.060 |
Why?
| | Antineoplastic Agents | 1 | 2017 | 2145 | 0.060 |
Why?
| | Skin Neoplasms | 1 | 2012 | 853 | 0.060 |
Why?
| | Melanocytes | 2 | 2017 | 66 | 0.060 |
Why?
| | Piperazines | 2 | 2017 | 351 | 0.060 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2017 | 868 | 0.050 |
Why?
| | Cell Line, Tumor | 3 | 2017 | 3420 | 0.050 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 1 | 2022 | 62 | 0.050 |
Why?
| | Transcription Factors | 1 | 2010 | 1717 | 0.050 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2022 | 125 | 0.050 |
Why?
| | Cell Survival | 2 | 2017 | 1122 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2010 | 2615 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 414 | 0.040 |
Why?
| | Genome, Fungal | 1 | 2018 | 41 | 0.040 |
Why?
| | Histone Chaperones | 1 | 2018 | 16 | 0.040 |
Why?
| | Gene Expression Regulation, Fungal | 1 | 2018 | 73 | 0.040 |
Why?
| | Cytochromes c | 1 | 2018 | 60 | 0.040 |
Why?
| | Transcriptional Elongation Factors | 1 | 2018 | 40 | 0.040 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2017 | 38 | 0.030 |
Why?
| | Mice | 3 | 2022 | 17843 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2017 | 116 | 0.030 |
Why?
| | Neurofibromin 1 | 1 | 2016 | 26 | 0.030 |
Why?
| | DNA Replication | 1 | 2018 | 242 | 0.030 |
Why?
| | DNA Repair | 1 | 2018 | 230 | 0.030 |
Why?
| | GTP Phosphohydrolases | 1 | 2016 | 91 | 0.030 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2016 | 81 | 0.030 |
Why?
| | Pyrroles | 1 | 2017 | 211 | 0.030 |
Why?
| | DNA Damage | 1 | 2018 | 420 | 0.030 |
Why?
| | Mutation | 2 | 2017 | 3964 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2022 | 3020 | 0.030 |
Why?
| | Mice, Nude | 1 | 2016 | 696 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2022 | 1979 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2018 | 324 | 0.030 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2016 | 227 | 0.030 |
Why?
| | Chromatin | 1 | 2018 | 524 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1255 | 0.030 |
Why?
| | Smad1 Protein | 1 | 2012 | 18 | 0.030 |
Why?
| | Microarray Analysis | 1 | 2012 | 116 | 0.020 |
Why?
| | Histones | 1 | 2018 | 641 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2016 | 806 | 0.020 |
Why?
| | DNA | 1 | 2018 | 1460 | 0.020 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2016 | 1060 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 948 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2016 | 1167 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2010 | 239 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2010 | 373 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2010 | 474 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2010 | 338 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2010 | 869 | 0.020 |
Why?
| | Temperature | 1 | 2010 | 680 | 0.020 |
Why?
| | Female | 3 | 2022 | 73162 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2017 | 4295 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2012 | 1402 | 0.020 |
Why?
| | Models, Molecular | 1 | 2010 | 1586 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2012 | 4206 | 0.010 |
Why?
| | Humans | 3 | 2017 | 137514 | 0.010 |
Why?
| | Male | 1 | 2022 | 67718 | 0.010 |
Why?
|
|
Almeida's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|